PCN102 Healthcare Resource Utilization (HCRU) and Costs with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIS) and Subsequent Chemotherapy Among Patients with LUNG Cancer
Abstract
Authors
L. Bartolome G. Siu B. Li R. Levin G. Devgan J. Ivanova